(Q37578027)

21 August 2017

1 reference

title

Severe asthma: what makes it so hard to manage? (English)

1 reference

21 August 2017

0 references

Luke Carlstrom

1

1 reference

21 August 2017

Mario Castro

series ordinal

2

1 reference

21 August 2017

publication date

1 September 2009

1 reference

Current Allergy and Asthma Reports

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

393-400

1 reference

Psychopathology in patients with severe asthma is associated with increased health care utilization

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-009-0057-7

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-009-0057-7

Factors associated with persistent airflow limitation in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-009-0057-7

Unsuspected pseudophysiologic emphysema in chronic persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-009-0057-7

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-009-0057-7

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

21 January 2018

1 reference

12 December 2020

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

12 December 2020

Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study

1 reference

12 December 2020

Airway inflammation in obese and nonobese patients with difficult-to-treat asthma

1 reference

12 December 2020

1 reference

12 December 2020

Non-eosinophilic cor ticosteroid unresponsive asthma

1 reference

12 December 2020

The link between fungi and severe asthma: a summary of the evidence.

1 reference

12 December 2020

Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study

1 reference

12 December 2020

Cluster analysis and clinical asthma phenotypes.

1 reference

12 December 2020

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.

1 reference

12 December 2020

Systematic assessment of difficult-to-treat asthma

1 reference

12 December 2020

A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.

1 reference

12 December 2020

The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma

1 reference

12 December 2020

Asthma severity is associated with body mass index and early menarche in women

1 reference

12 December 2020

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society

1 reference

12 December 2020

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

12 December 2020

The shape of the dose-response curve to histamine in asthmatic and normal subjects.

1 reference

12 December 2020

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children

1 reference

12 December 2020

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

1 reference

12 December 2020

"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids

1 reference

12 December 2020

Prevalence of psychiatric morbidity in a difficult asthma population: relationship to asthma outcome.

1 reference

12 December 2020

Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size

1 reference

12 December 2020

A new perspective on concepts of asthma severity and control.

1 reference

12 December 2020

Relationship between increased airway responsiveness and asthma severity in the childhood asthma management program

1 reference

12 December 2020

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma

1 reference

12 December 2020

Are overweight asthmatics more difficult to control?

1 reference

12 December 2020

Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma

1 reference

12 December 2020

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

1 reference

12 December 2020

Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis

1 reference

12 December 2020

Risk factors for near-fatal asthma

1 reference

12 December 2020

1 reference

12 December 2020

Psychiatric and medical features of near fatal asthma

1 reference

12 December 2020

Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma

1 reference

12 December 2020

A new asthma severity index: a predictor of near-fatal asthma?

1 reference

12 December 2020

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

12 December 2020

Parameters associated with persistent airflow obstruction in chronic severe asthma

1 reference

12 December 2020

Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome

1 reference

12 December 2020

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation

1 reference

12 December 2020

Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.

1 reference

12 December 2020

Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma

1 reference

12 December 2020

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma

1 reference

12 December 2020

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

1 reference

12 December 2020

Relationship between asthma severity and obesity

1 reference

12 December 2020

Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes

1 reference

12 December 2020

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

1 reference

12 December 2020

Chronic sinusitis in severe asthma is related to sputum eosinophilia

1 reference

12 December 2020

Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma.

1 reference

12 December 2020

Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma

1 reference

12 December 2020

Effect of weight reduction on respiratory function and airway reactivity in obese women.

1 reference

12 December 2020

1 reference

12 December 2020

Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma

1 reference

12 December 2020

Efficacy of esomeprazole for treatment of poorly controlled asthma

1 reference

12 December 2020

Body mass and glucocorticoid response in asthma.

1 reference

12 December 2020

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respira

1 reference

12 December 2020

Severe asthma: lessons from the Severe Asthma Research Program

1 reference

12 December 2020

Noneosinophilic asthma: a distinct clinical and pathologic phenotype

1 reference

12 December 2020

Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma

1 reference

12 December 2020

Psychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control study.

1 reference

12 December 2020

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

1 reference

12 December 2020

Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients

1 reference

12 December 2020

Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking

1 reference

12 December 2020

New targets for drug development in asthma

1 reference

12 December 2020

Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma

1 reference

12 December 2020

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

1 reference

12 December 2020

Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol

1 reference

12 December 2020

Relationship between airway obstruction and respiratory symptoms in adult asthmatics

1 reference

12 December 2020

Case-control study of severe life threatening asthma (SLTA) in adults: psychological factors

1 reference

12 December 2020

The response to combination therapy treatment regimens in severe/difficult-to-treat asthma

1 reference

12 December 2020

10.1007/S11882-009-0057-7

Identifiers

DOI

1 reference

21 August 2017

1 reference